|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistic, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park K, Tan EH, O'Byrne K, Zhang L, Boyer
M, Mok T, Hirsh V, Yang JC, Lee KH, Lu S, et al: Afatinib versus
gefitinib as first-line treatment of patients with EGFR
mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase
2B, open-label, randomised controlled trial. Lancet Oncol.
17:577–589. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nguyen KS, Kobayashi S and Costa DB:
Acquired resistance to epidermal growth factor receptor tyrosine
kinase inhibitors in non-small-cell lung cancers dependent on the
epidermal growth factor receptor pathway. Clin Lung Cancer.
10:281–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: Global surveillance of cancer survival 1995–2009: Analysis
of individual data for 25, 676, 887 patients from 279
population-based registries in 67 countries (CONCORD-2). Lancet.
385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okazaki Y, Furuno M, Kasukawa T, Adachi J,
Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, et al:
Analysis of the mouse transcriptome based on functional annotation
of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin, and development.
ScientificWorldJournal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moazed D: Small RNAs in transcriptional
gene silencing and genome defence. Nature. 457:413–420. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brosnan CA and Voinnet O: The long and the
short of noncoding RNAs. Curr Opin Cell Biol. 21:416–425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by Non-coding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhuang Y, Wang X, Nguyen HT, Zhuo Y, Cui
X, Fewell C, Flemington EK and Shan B: Induction of long intergenic
non-coding RNA HOTAIR in lung cancer cells by type I collagen. J
Hematol Oncol. 6:352013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai B, Song XQ, Cai JP and Zhang S:
HOTAIR: A cancer-related long non-coding RNA. Neoplasma.
61:379–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobayashi S, Boggon TJ, Dayaram T, Jänne
PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG and Halmos
B: EGFR mutation and resistance of non-small-cell lung cancer to
gefitinib. N Eng J Med. 352:786–792. 2005. View Article : Google Scholar
|
|
21
|
Pao W, Miller VA, Politi KA, Riely GJ,
Somwar R, Zakowski MF, Kris MG and Varmus H: Acquired resistance of
lung adenocarcinomas to gefitinib or erlotinib is associated with a
second mutation in the EGFR kinase domain. PLoS Med. 2:e732005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Engelman JA, Zejnullahu K, Mitsudomi T,
Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen
J, et al: MET amplification leads to gefitinib resistance in lung
cancer by activating ERBB3 signaling. Science. 316:1039–1043. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takezawa K, Pirazzoli V, Arcila ME, Nebhan
CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ,
Melnick MA, et al: HER2 amplification: A potential mechanism of
acquired resistance to EGFR inhibition in EGFR-mutant lung cancers
that lack the second-site EGFRT790M mutation. Cancer discov.
2:922–933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yano S, Yamada T, Takeuchi S, Tachibana K,
Minami Y, Yatabe Y, Mitsudomi T, Tanaka H, Kimura T, Kudoh S, et
al: Hepatocyte growth factor expression in EGFR mutant lung cancer
with intrinsic and acquired resistance to tyrosine kinase
inhibitors in a Japanese cohort. J Thorac Oncol. 6:2011–2017. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Whyte DB and Holbeck SL: Correlation of
PIK3Ca mutations with gene expression and drug sensitivity in
NCI-60 cell lines. Biochem Biophys Res Commun. 340:469–475. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Piotrowska Z, Niederst MJ, Karlovich CA,
Wakelee HA, Neal JW, Mino-Kenudson M, Fulton L, Hata AN, Lockerman
EL, Kalsy A, et al: Heterogeneity underlies the emergence of
EGFRT790 wild-type clones following treatment of T790M-positive
cancers with a third-generation EGFR inhibitor. Cancer discov.
5:713–722. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu HA, Arcila ME, Rekhtman N, Sima CS,
Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M and Riely GJ:
Analysis of tumor specimens at the time of acquired resistance to
EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.
Clin Cancer Res. 19:2240–2247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miller VA, Hirsh V, Cadranel J, Chen YM,
Park K, Kim SW, Zhou C, Su WC, Wang M, Sun Y, et al: Afatinib
versus placebo for patients with advanced, metastatic
non-small-cell lung cancer after failure of erlotinib, gefitinib,
or both and one or two lines of chemotherapy (LUX-Lung 1): A phase
2b/3 randomised trial. Lancet Oncol. 13:528–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21 (WAF1/CIP1) expression. PloS One.
8:e772932013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Yang S, Su N, Wang Y, Yu J, Qiu H
and He X: Overexpression of long non-coding RNA HOTAIR leads to
chemoresistance by activating the Wnt/β-catenin pathway in human
ovarian cancer. Tumour Biol. 37:2057–2065. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taylor RC, Cullen SP and Martin SJ:
Apoptosis: Controlled demolition at the cellular level. Nat Rev Mol
Cell Biol. 9:231–241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qiu JJ, Wang Y, Ding JX, Jin HY, Yang G
and Hua KQ: The long non-coding RNA HOTAIR promotes the
proliferation of serous ovarian cancer cells through the regulation
of cell cycle arrest and apoptosis. Exp Cell Res. 333:238–248.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zou M, Xia S, Zhuang L, Han N, Chu Q, Chao
T, Peng P, Chen Y, Gui Q and Yu S: Knockdown of the Bcl-2 gene
increases sensitivity to EGFR tyrosine kinase inhibitors in the
H1975 lung cancer cell line harboring T790M mutation. Int J Oncol.
42:2094–2102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yarden Y and Pines G: The ERBB network: At
last, cancer therapy meets systems biology. Nat Rev Cancer.
12:553–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang X and Lu S: MicroR-545 mediates
colorectal cancer cells proliferation through up-regulating
epidermal growth factor receptor expression in HOTAIR long
non-coding RNA dependent. Mol Cell Biochem. 431:45–54. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishikawa N, Daigo Y, Takano A, Taniwaki M,
Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, et
al: Increases of amphiregulin and transforming growth factor-alpha
in serum as predictors of poor response to gefitinib among patients
with advanced non-small cell lung cancers. Cancer Res.
65:9176–9184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Masago K, Fujita S, Hatachi Y, Fukuhara A,
Sakuma K, Ichikawa M, Kim YH, Mio T and Mishima M: Clinical
significance of pretreatment serum amphiregulin and transforming
growth factor-alpha, and an epidermal growth factor receptor
somatic mutation in patients with advanced non-squamous, non-small
cell lung cancer. Cancer sci. 99:2295–2301. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singh B and Coffey RJ: From wavy hair to
naked proteins: The role of transforming growth factor alpha in
health and disease. Semin Cell Dev Biol. 28:12–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shien K, Ueno T, Tsukuda K, Soh J, Suda K,
Kubo T, Furukawa M, Muraoka T, Maki Y, Tanaka N, et al: Knockdown
of the epidermal growth factor receptor gene to investigate its
therapeutic potential for the treatment of non-small-cell lung
cancers. Clin Lung Cancer. 13:488–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
